🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 12 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/01/2020 130,25 131,24 127,44 127,90 -1,84% 2,92% 862.500
16/01/2020 129,70 133,00 129,21 130,30 +0,05% 2,92% 751.300
15/01/2020 128,25 133,53 128,04 130,24 +1,81% 4,28% 1.095.900
14/01/2020 125,00 131,53 123,01 127,93 +2,65% 6,82% 1.734.600
13/01/2020 130,00 131,30 123,50 124,63 -3,40% 6,00% 1.777.100
10/01/2020 132,02 134,57 128,65 129,02 -1,99% 4,48% 832.500
09/01/2020 130,48 133,26 130,00 131,64 +1,24% 2,50% 780.200
08/01/2020 130,00 131,33 129,00 130,03 -0,15% 1,79% 1.011.500
07/01/2020 131,36 132,43 128,16 130,22 -0,94% 3,25% 738.000
06/01/2020 128,14 131,45 127,69 131,45 +1,29% 2,93% 810.600
03/01/2020 127,98 131,00 127,37 129,78 +0,53% 2,84% 628.600
02/01/2020 129,63 130,63 127,77 129,09 +0,04% 2,21% 580.900
31/12/2019 127,62 131,26 127,03 129,04 +0,19% 3,31% 555.500
30/12/2019 129,45 130,21 126,70 128,79 -0,76% 2,71% 648.800
27/12/2019 133,07 133,99 129,08 129,77 -2,41% 3,69% 807.800
26/12/2019 133,39 135,80 132,90 132,98 -0,98% 2,17% 527.000
24/12/2019 135,71 136,40 133,42 134,30 -0,94% 2,20% 838.400
23/12/2019 136,99 138,52 129,70 135,58 +7,46% 6,44% 4.186.900
20/12/2019 126,35 127,79 125,37 126,17 +0,69% 1,92% 1.413.600
19/12/2019 126,19 127,07 123,44 125,31 -1,03% 2,88% 1.216.900
18/12/2019 130,68 130,84 126,48 126,62 -3,69% 3,34% 1.446.200
17/12/2019 135,79 135,79 130,67 131,47 -2,87% 3,77% 1.103.800
16/12/2019 136,74 137,74 132,05 135,35 +2,50% 4,16% 2.051.700
13/12/2019 125,50 138,79 125,50 132,05 +31,43% 10,59% 10.791.300
12/12/2019 101,46 103,45 99,83 100,47 -0,97% 3,57% 1.113.900
11/12/2019 106,20 106,93 100,98 101,45 -4,45% 5,60% 1.171.300
10/12/2019 105,67 107,06 104,78 106,17 +0,40% 2,16% 1.078.300
09/12/2019 109,36 110,21 105,73 105,75 -3,39% 4,10% 876.600
06/12/2019 110,52 110,77 108,72 109,46 -0,45% 1,85% 573.500
05/12/2019 111,26 111,26 108,98 109,96 -1,27% 2,05% 664.000